Atenolol vs Durvalumab

## Atenolol vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Atenolol** and **Durvalumab**.

## Mechanism of Action

**Atenolol**: Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Atenolol — 6-7 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Atenolol — C14H22N2O3; Durvalumab — N/A.

**Molecular Weight**: Atenolol — 266.3360 g/mol; Durvalumab — N/A.

**Type**: Atenolol — Small molecule; Durvalumab — Antibody.